Journal of the American Medical Directors Association · 2025
Physician Billing in Long-Term Care Homes and the Association With the Prescribing of End-of-Life Symptom Management Medications: A Population-Based Retrospective Cohort Study.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Roberts Rhiannon L, Clarke Anna E, Howard Michelle, Dash Darly, Kobewka Daniel, Bush Shirley H, Sinnarajah Aynharan, Simon Jessica, Isenberg Sarina R, Arya Amit, Robert Benoit, Lau Jenny, Tanuseputro Peter, Downar James, Webber Colleen
Аннотация
OBJECTIVES: Medications are often needed to manage distressing end-of-life symptoms (eg, pain, agitation, dyspnea). We evaluated whether physician billing in long-term care (LTC) was associated with LTC residents' receipt of an end-of-life symptom management medication prescription.
DESIGN: Retrospective cohort study using administrative health data.
SETTING AND PARTICIPANTS: All LTC decedents in Ontario's 626 publicly funded LTC homes who died between January 1, 2017, and March 17, 2020, were matched to a physician most responsible for their care (MRP) in LTC.
METHODS: We measured the proportion of an MRP's billings that occurred in LTC. The prescribing of 1+ end-of-life symptom management medications was captured in LTC residents' last 2 weeks of life using prescription claims data.
RESULTS: The study included 54,445 LTC decedents and 1855 MRPs. MRPs had a median of 9% of their total billings in LTC (interquartile range 3% to 23%). Two-thirds of LTC decedents (36,682, 67.4%) had at least one end-of-life medication prescription, the most common of which was opioids (prescribed to 65.4% of decedents). There was no difference in the odds of a decedent having a prescription for an end-of-life medication based on their MRP's proportion of billings in LTC (adjusted odds ratio for a 10% increase in an MRPs' billings in LTC 1.01, 95% CI, 0.99-1.02).
CONCLUSIONS AND IMPLICATIONS: Across Ontario's LTC homes, there are large variations in prescribing rates for end-of-life symptom management medications; however, a physician's proportion of billings in LTC was not associated with a greater likelihood of prescribing.
DESIGN: Retrospective cohort study using administrative health data.
SETTING AND PARTICIPANTS: All LTC decedents in Ontario's 626 publicly funded LTC homes who died between January 1, 2017, and March 17, 2020, were matched to a physician most responsible for their care (MRP) in LTC.
METHODS: We measured the proportion of an MRP's billings that occurred in LTC. The prescribing of 1+ end-of-life symptom management medications was captured in LTC residents' last 2 weeks of life using prescription claims data.
RESULTS: The study included 54,445 LTC decedents and 1855 MRPs. MRPs had a median of 9% of their total billings in LTC (interquartile range 3% to 23%). Two-thirds of LTC decedents (36,682, 67.4%) had at least one end-of-life medication prescription, the most common of which was opioids (prescribed to 65.4% of decedents). There was no difference in the odds of a decedent having a prescription for an end-of-life medication based on their MRP's proportion of billings in LTC (adjusted odds ratio for a 10% increase in an MRPs' billings in LTC 1.01, 95% CI, 0.99-1.02).
CONCLUSIONS AND IMPLICATIONS: Across Ontario's LTC homes, there are large variations in prescribing rates for end-of-life symptom management medications; however, a physician's proportion of billings in LTC was not associated with a greater likelihood of prescribing.